Form 4: Repare Therapeutics EVP, CFO Steve Forte Sells Shares to Cover Tax Obligations

Steve Forte, EVP and CFO of Repare Therapeutics, sold a portion of his common shares to cover tax obligations related to the vesting of restricted stock units.

Summary

• Steve Forte, the EVP and CFO of Repare Therapeutics, sold common shares over three days from March 25 to March 27, 2024.
• The sales were executed to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
• These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on December 22, 2023.
• A total of 2,475 shares were sold across the three days.
• The sales prices ranged from $4.52 to $4.93 per share.
• Following these transactions, Forte still beneficially owns 42,212 common shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The share sales are related to tax obligations and were pre-planned, so they don't necessarily reflect a negative outlook on the company.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating they were planned and not based on sudden market changes or inside information.

Industry Context

Sales of shares to cover tax obligations upon vesting of RSUs are a common practice among company executives.

Stakeholder Impact

• The sale of shares by a company executive could be perceived negatively by some shareholders, although the context of tax obligations mitigates this concern.

Key Dates